Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps

被引:0
|
作者
Toppila-Salmi, Sanna [1 ,2 ,3 ,4 ]
Lyly, Annina [5 ,6 ]
Simin, Johanna [7 ]
Aakko, Juhani [7 ]
Olsen, Helga Haugom [5 ]
Lehtimaki, Lauri [8 ,9 ]
机构
[1] Univ Eastern Finland, Dept Otorhinolaryngol, Kuopio, Finland
[2] Wellbeing Serv Cty Pohjois Savo, Dept Otorhinolaryngol, Kuopio, Finland
[3] Helsinki Univ Hosp, Inflammat Ctr, Dept Allergol, Helsinki, Finland
[4] Univ Helsinki, Helsinki, Finland
[5] AstraZeneca Nordics, Med Affairs, Espoo, Finland
[6] AstraZeneca Nordics, Med & Regulatory, Oslo, Norway
[7] Medaffcon Oy, Espoo, Finland
[8] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[9] Tampere Univ Hosp, Allergy Ctr, Tampere, Finland
关键词
chronic rhinosinusitis; CRSwNP; endoscopic surgery; nasal polyps; revision surgery; PREVALENCE; GUIDELINES; OUTCOMES; ASTHMA;
D O I
10.1002/clt2.70032
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background Although patients with chronic rhinosinusitis with nasal polyps (CRSwNP) may benefit from endoscopic sinus surgery (ESS), some patients will experience polyp recurrence, adding to the overall disease burden of CRSwNP. We aimed to investigate predictors of revision ESS in patients with CRSwNP. Methods A nationwide population-based study including all adults diagnosed with CRSwNP who had surgical procedure codes for ESS (N = 3506), followed up between January 2012 and December 2019. Logistic regression models provided adjusted odds ratios (OR) with 95% confidence intervals (CIs) for the odds of revision surgery within one and 3 years post-index surgery. Results 559 (15.9%) of the patients had at least one revision surgery during the follow-up. Median time to revision of ESS was 425 days (interquartile range: 213-898). Baseline asthma (OR = 1.58, 95% CI 1.17-2.12) and antibiotic use (OR = 1.61, 95% CI 1.27-2.04) were associated with higher odds of revision ESS, particularly within 3 years post-index surgery, whereas Increasing age was inversely associated with the odds of ESS revision (OR = 0.82, 95% CI 0.76-0.88). The highest odds of revision ESS were observed within 3 years post-index surgery in patients who had undergone extensive surgery at index (OR = 14.13, 95% CI 3.41-95.64) compared with those who had undergone limited surgery. OCS use was frequent among CRSwNP patients, with a higher cumulative dose in patients undergoing multiple ESS revisions (63%, n = 97, median daily dose 3.29 mg, IQR: 1.64-3.70) compared with patients without revisions (49%, n = 1361 and 1.64 mg, IQR: 1.64-3.29, respectively. p-value <0.001). Conclusions A small proportion of CRSwNP patients require revision ESS with associated high cumulative OCS doses, highlighting the need for additional therapies to achieve disease control and reduce the corticosteroid burden. A few simple baseline characteristics can predict the need for recurrent surgery among the patients with CRSwNP.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Predictors of olfactory improvement after endoscopic sinus surgery in chronic rhinosinusitis with nasal polyps
    Hernandez, A. K.
    Wendler, O.
    Mayr, S.
    Iro, H.
    Hummel, T.
    Mueller, S. K.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2023, 137 (05): : 524 - 531
  • [2] Characteristics of Chronic Rhinosinusitis with Nasal Polyps Based on Allergic Mucin and Fungal Elements in Patients Undergoing Revision Endoscopic Sinus Surgery
    Lisa Mary Cherian
    Rakesh R. Bright
    Lalee Varghese
    V. Rupa
    Regi Kurien
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2022, 74 : 108 - 115
  • [3] Characteristics of Chronic Rhinosinusitis with Nasal Polyps Based on Allergic Mucin and Fungal Elements in Patients Undergoing Revision Endoscopic Sinus Surgery
    Cherian, Lisa Mary
    Bright, Rakesh R.
    Varghese, Lalee
    Rupa, V
    Kurien, Regi
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (01) : 108 - 115
  • [4] Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps
    Dharmarajan, Harish
    Falade, Oluleke
    Lee, Stella E.
    Wang, Eric W.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2022, 12 (08) : 986 - 995
  • [5] Risk factors for recurrence of chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery
    Fageeh, Yahya A.
    Basurrah, Mohammed A.
    Hakami, Khalid T.
    Almalki, Zohour A.
    Alnemari, Farah S.
    Altalhi, Wahaj A.
    SAUDI MEDICAL JOURNAL, 2023, 44 (12) : 1254 - 1259
  • [6] Prognostic factors for recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps
    Nakayama, Tsuguhisa
    Asaka, Daiya
    Kanaya, Hiroaki
    Kuboki, Akihito
    Haruna, Shin-ichi
    AURIS NASUS LARYNX, 2016, 43 (06) : 641 - 647
  • [7] Endoscopic Extended Sinus Surgery for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps, the Choice of Mucoplasty: A Systematic Review
    Martin-Jimenez, Daniel
    Moreno-Luna, Ramon
    Cuvillo, Alfonso
    Gonzalez-Garcia, Jaime
    Maza-Solano, Juan
    Sanchez-Gomez, Serafin
    CURRENT ALLERGY AND ASTHMA REPORTS, 2023, 23 (12) : 733 - 746
  • [8] Endoscopic Extended Sinus Surgery for Patients with Severe Chronic Rhinosinusitis with Nasal Polyps, the Choice of Mucoplasty: A Systematic Review
    Daniel Martin-Jimenez
    Ramon Moreno-Luna
    Alfonso Cuvillo
    Jaime Gonzalez-Garcia
    Juan Maza-Solano
    Serafin Sanchez-Gomez
    Current Allergy and Asthma Reports, 2023, 23 : 733 - 746
  • [9] Endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps: Clinical outcome and predictive factors of recurrence
    Veloso-Teles, Rafaela
    Cerejeira, Rui
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2017, 31 (01) : 56 - 62
  • [10] Improvement of Subjective Olfactory Dysfunction in Chronic Rhinosinusitis With Nasal Polyps After Endoscopic Sinus Surgery
    Ye, Ping
    He, Shaojuan
    Tang, Shuangmei
    Xie, Xinyu
    Duan, Chen
    Zhang, Liqiang
    Steinke, John W.
    Borish, Larry
    Li, Xuezhong
    Feng, Xin
    FRONTIERS IN SURGERY, 2022, 9